• Sonata 20: New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions UMO-2024/55/D/NZ7/01736
  • Budget: 2 097 021 PLN (ca 500 000 EUR)
  • Realization: 2025-2028
• Opus 27: Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy UMO-2024/53/B/NZ7/02801
  • Budget: 2 996 771 PLN (ca 700 000 EUR)
  • Realization: 2025-2029